Related Experiment Video
Updated: Jul 1, 2026
13:34
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation.
John P Sinek1, Sandeep Sanga, Xiaoming Zheng
1Department of Mathematics, University of California, Irvine, CA, USA.
Journal of Mathematical Biology
|September 11, 2008
Summary
Tumor heterogeneity significantly impacts chemotherapy efficacy. Simulations reveal that drug distribution and nutrient levels, not just genetics, dictate treatment success for doxorubicin and cisplatin, influencing clinical resistance.
Area of Science:
- Pharmacokinetics and pharmacodynamics
- Computational biology
- Cancer therapy modeling
Background:
- Vascularized tumors exhibit complex heterogeneity impacting drug delivery and efficacy.
- Understanding determinants of drug distribution is crucial for optimizing cancer treatments.
- Existing models often simplify tumor microenvironment complexities.
Purpose of the Study:
- To investigate the pharmacokinetics and effects of doxorubicin and cisplatin in vascularized tumors using 2D simulations.
- To analyze the impact of vascular, morphological, and cellular heterogeneity on drug distribution and therapeutic outcomes.
- To quantify the influence of nutrient levels and drug efflux on treatment efficacy.
Main Methods:
- Developed a multi-compartment pharmacokinetic-pharmacodynamic (PKPD) model.
- Calibrated the model using published experimental data.
- Simulated 2-hour bolus administrations followed by 18-hour drug washout.
- Quantified distributions of nutrients, drugs, and cell inhibition.
Main Results:
- Significant heterogeneity in drug, nutrient, and cell inhibition distributions was observed.
- Increased serum drug concentrations were required for effective tumor inhibition.
- Hypoxia and hypoglycemia exacerbated doxorubicin's heterogeneity and doubled the required inhibitory concentration (IC50).
- Cisplatin showed more uniform distribution than doxorubicin, simplifying efficacy prediction.
- In vitro assays may predict in vivo performance better for uniformly distributed drugs like cisplatin.
Conclusions:
- Lesion-scale drug and nutrient distribution significantly impact therapeutic efficacy, comparable to genetic factors.
- Heterogeneity in drug distribution and nutrient effects contribute to clinical resistance.
- Understanding these complex interactions is vital for predicting and improving chemotherapy success.
- Therapeutic strategies must account for tumor microenvironment variability for optimal outcomes.
More Related Videos
Related Concept Videos
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.